Apr 10, 2018

Oncolytics Biotech(R) Presents Positive REOLYSIN(R) Data in Combination with Keytruda and anti-CD73 at International Oncolytic Virus Conference 2018

Apr 4, 2018

Oncolytics Biotech(R) to Present at the MicroCap Conference

Mar 20, 2018

Oncolytics Biotech(R) Scientist Selected to Participate in the Society of Immunotherapy of Cancer's (SITC) METIOR Incubator Program

Mar 14, 2018

Oncolytics Biotech(R) Announces Publication of REOLYSIN(R) Abstract for the AACR 2018 Annual Meeting

Mar 9, 2018

Oncolytics Biotech(R) Inc. Announces 2017 Year-End Results

Mar 8, 2018

Oncolytics Biotech(R) Chief Medical Officer to Facilitate Roundtable Discussion at the US Immuno-Oncology Strategy Meeting

Feb 27, 2018

Oncolytics Biotech(R) to Present REOLYSIN(R) at the 2018 Precision: Breast Cancer World R&D Summit

Feb 23, 2018

Oncolytics Biotech(R) Announces Results from Special Meeting of Shareholders

Feb 14, 2018

Oncolytics Biotech(R) to Present at the RBC Capital Markets 2018 Healthcare Conference

Feb 1, 2018

Oncolytics Biotech(R) to Host Conference Call Outlining the Treatment Paradigm of Metastatic Breast Cancer Subtypes and Provide Topline Information on its Phase 3 Registration Study with REOLYSIN(R)